Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 7 | 2021 | 1204 | 0.880 |
Why?
|
| Heart-Assist Devices | 4 | 2017 | 731 | 0.770 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 111 | 0.560 |
Why?
|
| Cardiac Catheterization | 4 | 2019 | 291 | 0.550 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2017 | 130 | 0.530 |
Why?
|
| Heart Ventricles | 2 | 2019 | 760 | 0.500 |
Why?
|
| Pneumonectomy | 2 | 2013 | 196 | 0.480 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 1075 | 0.470 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 218 | 0.470 |
Why?
|
| Survivors | 1 | 2013 | 226 | 0.410 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 2262 | 0.370 |
Why?
|
| Popliteal Artery | 2 | 2020 | 27 | 0.370 |
Why?
|
| Absorbable Implants | 2 | 2020 | 34 | 0.360 |
Why?
|
| Angioplasty, Balloon | 2 | 2020 | 95 | 0.350 |
Why?
|
| Peripheral Arterial Disease | 2 | 2020 | 88 | 0.340 |
Why?
|
| Ischemia | 2 | 2020 | 243 | 0.320 |
Why?
|
| Hemodynamics | 3 | 2019 | 711 | 0.270 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 1077 | 0.260 |
Why?
|
| Retrospective Studies | 12 | 2023 | 8496 | 0.260 |
Why?
|
| Radial Artery | 2 | 2022 | 33 | 0.260 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1169 | 0.250 |
Why?
|
| Treatment Outcome | 8 | 2024 | 7998 | 0.230 |
Why?
|
| Cysteine | 1 | 2024 | 135 | 0.230 |
Why?
|
| Myocardial Ischemia | 1 | 2024 | 162 | 0.220 |
Why?
|
| Ulnar Artery | 1 | 2022 | 5 | 0.210 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2013 | 468 | 0.200 |
Why?
|
| Chitosan | 1 | 2021 | 18 | 0.200 |
Why?
|
| Myocardial Infarction | 1 | 2024 | 376 | 0.190 |
Why?
|
| Hemostatics | 1 | 2021 | 56 | 0.190 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 58 | 0.190 |
Why?
|
| Neoadjuvant Therapy | 2 | 2013 | 318 | 0.190 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2021 | 107 | 0.180 |
Why?
|
| Heart Transplantation | 2 | 2023 | 705 | 0.180 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 350 | 0.170 |
Why?
|
| Middle Aged | 10 | 2020 | 25040 | 0.170 |
Why?
|
| Septal Occluder Device | 1 | 2019 | 42 | 0.170 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2019 | 67 | 0.170 |
Why?
|
| Male | 11 | 2022 | 40988 | 0.170 |
Why?
|
| Pulmonary Embolism | 1 | 2021 | 222 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 243 | 0.170 |
Why?
|
| Furosemide | 1 | 2018 | 33 | 0.160 |
Why?
|
| Female | 11 | 2022 | 44550 | 0.160 |
Why?
|
| Diuretics | 1 | 2018 | 124 | 0.160 |
Why?
|
| Humans | 19 | 2024 | 86678 | 0.160 |
Why?
|
| Coronary Angiography | 3 | 2024 | 232 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 257 | 0.150 |
Why?
|
| Dopamine | 1 | 2018 | 275 | 0.140 |
Why?
|
| Aged | 8 | 2020 | 18423 | 0.140 |
Why?
|
| Adult | 7 | 2024 | 25659 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 125 | 0.130 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 462 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2016 | 134 | 0.120 |
Why?
|
| Kentucky | 1 | 2013 | 14 | 0.120 |
Why?
|
| Risk Factors | 4 | 2021 | 5420 | 0.120 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2013 | 35 | 0.110 |
Why?
|
| Heart | 1 | 2016 | 539 | 0.110 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 142 | 0.110 |
Why?
|
| Time Factors | 3 | 2020 | 5214 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1019 | 0.110 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 292 | 0.110 |
Why?
|
| Motor Activity | 1 | 2014 | 327 | 0.100 |
Why?
|
| Prognosis | 2 | 2017 | 3680 | 0.100 |
Why?
|
| Physicians | 1 | 2019 | 674 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 346 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2014 | 212 | 0.100 |
Why?
|
| Echocardiography | 1 | 2016 | 911 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 861 | 0.100 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 380 | 0.090 |
Why?
|
| United States | 3 | 2019 | 6681 | 0.090 |
Why?
|
| Vascular Patency | 2 | 2020 | 126 | 0.090 |
Why?
|
| Registries | 1 | 2013 | 703 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2017 | 2264 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2012 | 1538 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2012 | 288 | 0.080 |
Why?
|
| Obesity | 1 | 2014 | 964 | 0.080 |
Why?
|
| Age Factors | 1 | 2012 | 1852 | 0.080 |
Why?
|
| Stroke Volume | 2 | 2021 | 456 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 827 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2017 | 2207 | 0.070 |
Why?
|
| Prevalence | 2 | 2023 | 1239 | 0.070 |
Why?
|
| Acute Disease | 2 | 2018 | 826 | 0.060 |
Why?
|
| Vascular Resistance | 1 | 2024 | 102 | 0.060 |
Why?
|
| Microcirculation | 1 | 2024 | 106 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2024 | 130 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 121 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2024 | 177 | 0.050 |
Why?
|
| Spasm | 1 | 2022 | 16 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 34 | 0.050 |
Why?
|
| Catheters | 1 | 2021 | 74 | 0.050 |
Why?
|
| Hemostatic Techniques | 1 | 2021 | 14 | 0.050 |
Why?
|
| Hemostasis | 1 | 2021 | 21 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2021 | 84 | 0.050 |
Why?
|
| Limb Salvage | 1 | 2020 | 33 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2023 | 464 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3642 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6513 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 119 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 350 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 278 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 294 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 244 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 840 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2018 | 430 | 0.040 |
Why?
|
| Creatinine | 1 | 2018 | 339 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 592 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2019 | 344 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 973 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 895 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 816 | 0.030 |
Why?
|
| Natriuretic Agents | 1 | 2015 | 2 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1864 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 88 | 0.030 |
Why?
|
| Brazil | 1 | 2014 | 69 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2015 | 175 | 0.030 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2019 | 516 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1802 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 327 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2768 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2504 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 4214 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 1532 | 0.020 |
Why?
|